Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose versus single-dose hepatitis B vaccine in nurses
IRCT201405051155N18Phase 3Completed
- Sponsor
- Research Vice Chancellorship of Guilan University of Medical Sciences
- Start
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by Research Vice Chancellorship of Guilan University of Medical Sciences. Primary endpoint: Immunogenicity of hepatitis B vaccine (double vs single dose). Started Mar 2013; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on IRCT201405051155N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201405051155N18.